Board of Directors

Mrs. Claire Giraut brings to Grifols her extensive executive and non-executive experience in the corporate and financial world, in leading international companies in the healthcare and other industrial sectors.

Since 2022, Mrs. Claire Giraut has been a member of the Board of Directors and Chair of the Audit Committee of Euroapi, a company specializing in active ingredient solutions for the pharmaceutical industry, based in Paris. In addition, since 2021, she chairs the Financial Committee of the Institut Curie, a recognized cancer research and treatment center in Paris. Previously, from 2010 to 2022 she was a member of the Board of Directors and of the Audit Committee of Julius Baer, a leader in private banking based in Zurich, and from 2020 to 2022 the Chair of its Development and Innovation Committee. In addition, from 2016 to 2021, Mrs. Claire Giraut was a member of the Board of Directors and Chair of the Audit Committee of DBV Technologies, a clinical-stage biotechnology company. Before that, from 2010 to 2016, she was a member of the Board of Directors and of the Audit Committee of Heurtey Petrochem, an engineering and construction company based in Paris.

In terms of executive experience, Mrs. Claire Giraut has held senior financial roles in internationally renowned companies. From 2013 to 2018, she was the Executive Vice President and Chief Financial Officer of BioMérieux, a global in-vitro diagnostics company. Prior to joining BioMérieux, in 2011-2012 she was Chief Financial Officer of Europcar Group in Paris, and from 2003 to 2011 she was Executive Vice President and Chief Financial Officer of IPSEN, a pharmaceutical company based in Paris. She also held senior positions at Technip, a leading engineering company based in Paris, and at Coflexip Stena Offshore, a subsea oil and gas engineering and construction company.

On the academic side, Mrs. Claire Giraut holds a Master's degree in Agronomy from the Institut National Agronomique de Paris, now known as AgroParisTech.